Undervalued Large-Cap Healthcare Stocks on NYS November 2024

November 15, 2024

Healthcare Sector

The healthcare sector includes companies in biotechnology, pharmaceuticals, hospitals, home and long-term care. It also includes related medical equipment manufacturers and suppliers.

New York Stock Exchange

The New York Stock Exchange, located in New York City, is the largest securities exchange in the world by market capitalization of its listed companies.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Healthcare stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
OGN Organon 15.31 32.05 109.34 2882504 3977 7.32 3.0
OSCR Oscar Health 15.44 28.53 84.81 4747529 3754 0.00 0.0
CTLT Catalent 58.91 82.38 39.84 1861533 10722 0.00 0.0
AVTR Avantor 21.15 28.01 32.44 6444257 14445 0.00 47.0
ELAN Elanco Animal Health 14.04 18.26 30.06 4791100 6988 0.00 34.2
PEN Penumbra 233.51 286.57 22.72 387204 9149 0.00 268.4
GSK GSK 34.39 41.56 20.83 6898781 71204 4.45 22.2
MTD Mettler-Toledo Intl 1237.78 1480.84 19.64 148902 26293 0.00 33.4
BIO.B Bio-Rad Laboratories 334.85 399.73 19.37 - 9371 0.00 0.0
NVS Novartis 103.40 123.39 19.34 1265342 209592 3.65 18.0
All data provided as at market close November 13, 2024.

Company Details

Organon

OGN:NYS

Close Price

15.31

Our Valuation

32.05

% Difference

109.34

Market Cap ($M)

3977

P/E Ratio

3.0

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan.

Access the stockcalc valuation


Oscar Health

OSCR:NYS

Close Price

15.44

Our Valuation

28.53

% Difference

84.81

Market Cap ($M)

3754

P/E Ratio

0.0

Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.

Access the stockcalc valuation


Catalent

CTLT:NYS

Close Price

58.91

Our Valuation

82.38

% Difference

39.84

Market Cap ($M)

10722

P/E Ratio

0.0

Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers.

Access the stockcalc valuation


Avantor

AVTR:NYS

Close Price

21.15

Our Valuation

28.01

% Difference

32.44

Market Cap ($M)

14445

P/E Ratio

47.0

Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Elanco Animal Health

ELAN:NYS

Close Price

14.04

Our Valuation

18.26

% Difference

30.06

Market Cap ($M)

6988

P/E Ratio

34.2

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries.

Access the stockcalc valuation


Penumbra

PEN:NYS

Close Price

233.51

Our Valuation

286.57

% Difference

22.72

Market Cap ($M)

9149

P/E Ratio

268.4

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets.

Access the stockcalc valuation


GSK

GSK:NYS

Close Price

34.39

Our Valuation

41.56

% Difference

20.83

Market Cap ($M)

71204

P/E Ratio

22.2

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Access the stockcalc valuation


Mettler-Toledo Intl

MTD:NYS

Close Price

1237.78

Our Valuation

1480.84

% Difference

19.64

Market Cap ($M)

26293

P/E Ratio

33.4

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 39%), and food retail (around 6%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances.

Access the stockcalc valuation


Bio-Rad Laboratories

BIO.B:NYS

Close Price

334.85

Our Valuation

399.73

% Difference

19.37

Market Cap ($M)

9371

P/E Ratio

0.0

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories.

Access the stockcalc valuation


Novartis

NVS:NYS

Close Price

103.40

Our Valuation

123.39

% Difference

19.34

Market Cap ($M)

209592

P/E Ratio

18.0

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Organon and Oscar Health are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-november-2024
Organon $OGN and Oscar Health $OSCR are the most undervalued Healthcare stocks on the #NYS. See the full list: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-november-2024
Organon and Oscar Health are the most undervalued Large-Cap Healthcare stocks on the NYS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-large-cap-healthcare-stocks-nys-november-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.